What’s happening in 2021
Virtual series:
Are you interested knowing the questions on how to achieving scalable enzymatic processes in industry, how to improve your protein design through AI/ML models, how to develop novel mutant libraries and what the role directed evolution within food and beverage market within Japan? Then you can find all the answers through our online series through March, May and July. Are you looking for one place to find the right enzyme(s) or industry biocatalyst lead? Then join our connect sessions which will facilitate protein engineering matchmaking opportunities across multiple industries.
The main event:
We will be returning with live events in sept 8-9th in the US and November 23-24th in Europe to discuss the late development within directed evolution, computational protein design & AI, synthetic and white biotechnology, and real-world applications of engineered enzymes relevant. Bringing together 300+ attendees to within pharmaceutical, flavour & fragrance, fine chemical, agrochemical, and food industries.
Advisory Board
Each of our Advisory Board members have been chosen based on numerous recommendations, their deep knowledge and Industry experience and ability to provide a clear vision, not just for their own organizations, but for the industry as a whole.
WHY THEY ARE HERE
Board members guide not just content, but also the underlying mission of the events to drive positive change.
As a Senior Team Leader, Jared's primary role at BASF Enzymes LLC is to develop and implement robust platforms for enzyme discovery, evolution, and bioresources management. This includes integrating laboratory automation, digital workflow tracking, and state of the art molecular biology technologies with the design-build-test-learn framework for the optimization of commercial enzymes. BASF Enzymes develops, produces, and markets a diverse portfolio of enzymes products used in animal nutrition, baked goods, bioenergy, home care and industrial and institutional solutions as well as pulp and paper and oilfield solutions.
"We are currently in an unprecedented era in which we can design, engineer, and evaluate enzymes at will, bound only by the limits of our creativity. By intelligently surveying these vast genetic landscapes we have the exciting opportunity to unlock sustainable solutions to a variety of global industrial challenges."
Juan E. Velasquez is currently a Group Scientist at the Corporate R&D Organization of The Procter & Gamble Company in Cincinnati, Ohio (USA). Since joining P&G in 2011, his research has focused on the discovery and development of novel enzymes and other biomaterials and their application in consumer products.
“Enzymatic technologies have transformed the detergents industry by enabling superior, quicker, and environmentally friendlier cleaning solutions. But the journey just started. The rapidly evolving techniques on enzyme engineering will continue accelerating innovation and improving the lives of consumers for generations.”
Julien Hitce, graduated in France from “Chimie Paris” in 2004, with a Master's degree in Chemical Science. He started his journey into Green Chemistry with his PhD (2004-2007), focused on the development of new methodologies and synthetic applications featuring transition-metal catalyzed transformations, especially C–H activation.
After a postdoctoral stay at Stanford (USA), in the B.M. Trost research group, focused on the development of a novel, enantioselective, atom-economical transformation, he joined L’OREAL Research & Innovation in 2009.
He is currently heading a research group dedicated to the development of new cosmetic ingredients, leveraging the potential of Green Chemistry and innovative transformation technologies for skincare and make-up applications.
Research interests:
- Design and synthesis of novel cosmetic ingredients for skin- and hair-care, with a major focus on Color, Optics and UV-protection
- Green Chemistry with a focus on transformations and processes that straightforwardly generate structural complexity/diversity and added-value from renewable building-blocks
- Process development toward industrialization with a focus on limiting the environmental impact of the process.
“Biocatalysis has emerged as a powerful route toward products that combine both performance and sustainability. And new developments will bring new opportunities: a great promise for green synthesis!”
Reinhard Sterner studied Biology (Diploma) at the University of Munich (Germany) from where he graduated in 1988. He performed his doctoral studies at the same university and obtained a PhD in 1991 under the supervision of Prof. Heinz Decker. He then moved on to the Biocentre of the University of Basel (Switzerland) where he worked as a postdoctoral fellow with Prof. Kasper Kirschner and completed his Habilitation in Biochemistry in 1996. Reinhard Sterner was then awarded a Heisenberg fellowship from the German Research foundation (DFG), which enabled him in 1997 to set up a junior research group at the University of Göttingen (Germany). In 1999, he was appointed associate professor of Biochemistry at the University of Cologne (Germany). In 2004, he relocated to the University of Regensburg (Germany) where he has been working since then as a full professor of Biochemistry. The main research interests of Prof. Sterner are enzyme engineering, enzyme evolution, and the structure-function relationship of multi-enzyme complexes.
"The engineering of existing enzymes and the design of novel enzymes with a preconceived combination of stability and activity is a highly ambitious and relevant goal of protein biochemistry. Our ability to generate such tailored enzymes would have great implications for our understanding of the structure-function relationship of proteins and holds promise for many medical and biotechnological applications."
Why Attend
Most enzymes found in nature are not suitable for industrial purposes. The ability to design, engineer and modify biocatalysts has opened the doors to entirely new enzymatic applications, and the need to optimize reactions and embrace green chemistry globally is greater than ever.
The Protein Engineering Global series is dedicated to uncovering the new and emerging practices, techniques, and methods of protein and enzyme engineering across industries.
With pharmaceutical, flavour & fragrance, consumer goods, food & beverage and agrochemical sectors all approaching the design, build and generation of new biocatalysts and molecules not found in nature, come and learn from our leading speaker faculty to find out how new technologies are being used in the field of strain and protein engineering.
Join the community and you'll be able to; improve your ability to industrialise sustainable enzyme products, increase your product pipeline, increase product efficiency and increase differentiation by meeting the experts in the biocatalysis and protein engineering space.
This is not your average protein engineering series...it's about industry, sharing knowledge, finding the right enzyme provider and optimising your protein engineering method for the best outcomes.
Our 2020 Speakers

Frances Arnold
Frances Arnold’s work has been recognised by many awards including the 2018 Nobel Prize in Chemistry for pioneering the use of directed evolution to engineer enzymes. Arnold is co-inventor on over 40 US patents. Throughout her esteemed career and many achievements, Frances Arnold co-founded Gevo, Inc a company to make fuels and chemicals from renewable resources in 2005. She has been on the corporate board of the genomics company Illumina Inc since 2016 and in 2019, she was named to the board of Alphabet Inc., making Arnold the third female director of the Google parent company.
At Caltech, Arnold runs a laboratory that continues to study directed evolution and its applications in environmentally friendly chemical synthesis and green/alternative energy, including the development of highly active enzymes (cellulolytic and biosynthetic enzymes) and microorganisms to convert renewable biomass to fuels and chemicals.

Andrew Buller

Hans Renata

Jared Lewis

Jeremy Steflik

Joelle Pelletier

Justin Siegel

Lori Giver

Jim Lalonde

Maria Lucas

Richard Fox

Rudi Fasan

Ryan Phelan

Stefan Lutz

Todd Hyster

Trish Choudhary

Yasuhisa Asano

John Tucker

Toby Richardson

Christina Boville

David Entwistle

Dr Christian Gruber
Testimonials
Meet attendees from companies including:

Become a Sponsor
Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].
Download the Agenda
While we are working on our 2021 program, feel free to download a copy of our 2020 agenda to get an idea of what we were up to this year!
Download Agenda
Headline Sponsor
GenScript
Website: https://www.genscript.com/
GenScript Biotech is the world leader in biotechnology reagent service industry. Established in 2002 in New Jersey, United States, the company was the first to commercialize gene synthesis and successfully establish fully integrated capabilities for custom peptide synthesis, protein expression and engineering, custom antibody development and engineering, animal model development, in vitro/in vivo pharmacology as well as a variety of catalogue products, industrial enzymes and microbial reagents.
Senior Event Partner
ATUM
Website: http://www.atum.bio
ProteinGPS is an engineering technology that can modify proteins for real world applications. A small number of variants are tested using high quality assays representative of the functionality, developability and manufacturability properties that your protein will need. Iterative machine learning and testing steps result in an engineered protein that will work where it matters: the real world.
Twist Biosciences
Website: https://www.twistbioscience.com/
At Twist Bioscience, we work in service of customers who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals and data storage, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. The faster our customers succeed, the better for all of us, and Twist Bioscience is uniquely positioned to help accelerate their efforts.
Our innovative silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis and sequencing, providing both the quality and quantity of the tools they need to rapidly realize the opportunity ahead. For more information about our products and services, please visit www.twistbioscience.com. Twist Bioscience is on Twitter. Sign up to follow our Twitter feed @TwistBioscience at https://twitter.com/TwistBioscience.
Zymvol
Website: https://zymvol.com/
Zymvol Biomodeling SL is a privately-owned company based out in Barcelona, Spain.
We are specialized in the discovery and optimization of enzymes for the biocatalytic synthesis of small molecules. We apply proprietary computational technologies that combines bioinformatics, 3D molecular modeling, and Quantum Mechanics to identify and engineering your enzymes in less than 4 weeks. We deliver samples of enzymes identified in any Enzyme Search or In Silico Design campaigns for our clients’ in-house validation. We take into account parameter like activity, selectivity, specificity, stability and solubility.
Event Partner
Biocatalysts
Website: https://www.biocatalysts.com/enzyme-development-manufacture/
Biocatalysts develop and manufacture speciality enzymes from small to large scale quantities for a variety of industries, such as food, flavour & fragrance, life science, pharma and fine chemicals. We are the only company offering a rapid, low-cost speciality enzyme service from discovery phase through to global shipment of regulatory compliant enzymes.
Codexis
Website: http://www.codexis.com
Codexis, Inc. is a leading protein engineering company applying innovative technologies to unlock the power of proteins®.
Since 2002, Codexis’ scientists and bioinformatics experts have worked collaboratively with our clients to advance protein optimization and production, enabling breakthrough developments in pharmaceuticals and fine chemicals, biotherapeutics, food & beverage, agriculture and a wide range of other industries.
Guided by proprietary software and bioinformatic systems, Codexis leverages existing knowledge and expertise to improve protein stability, activity, specificity and other properties to enhance clinical function or process performance.
Our proprietary CodeEvolver® technology platform enables the rapid development and production of highly optimized proteins, custom-designed for your application. Codexis’ revolutionary approach to protein engineering starts with an understanding of the desired performance specifications and optimizes a protein specifically to fit these requirements. You get precisely the protein you need for the job you want it to do.
Denovium Inc
Website: http://www.denovium.com
Denovium is an artificial intelligence company pioneering novel AI methods to accelerate innovation in biopharma. Founded by genomics experts, we have spent decades solving complex biological problems and are passionate about creating life-changing AI solutions that will revolutionize the industry’s scientific approach.
Innophore
Website: https://innophore.com/
Innophore uses the patented 3D point cloud technology (so called Catalophores) to identify enzymes for biocatalytic industrial processes.
The search in a proprietary database of active site cavities allows customers to find new enzymes that are otherwise unpredictable.
The platform is a digital search engine for partners in the fields of pharma, chemistry, biotechnology, food, cosmetics, agriculture, textiles or diagnostics.
Artificial intelligence is applied to refine searches and get the most out of our proprietary database.
Proteus by Seqens
Website: https://www.proteus.seqens.com/en/
Please visit our website for more information.About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.